Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company, based in South San Francisco, was founded in 2012 by Dr. Karl Hostetler of The University of California San Diego.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/30/17 | $22,000,000 | Series C |
Alexandria Real Estate Equities Canaan Partners Nadav Peres  NS Investment Osage University Partners Sofinnova Ventures | undisclosed |
